Cited by 860Cancer, Hypoxia, and MetabolismAmino Acid Enzymes and MetabolismBacterial Cancer Therapy

The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.

Glutaminolysis: A Hallmark of Cancer Metabolism

Open access

Yang, Lifeng, Venneti, Sriram, Nagrath, Deepak·2017·Annual Review of Biomedical Engineering

DOI 10.1146/annurev-bioeng-071516-044546

Open this paper in CoChat — free account Open PDF

Abstract

Glutamine is the most abundant circulating amino acid in blood and muscle and is critical for many fundamental cell functions in cancer cells, including synthesis of metabolites that maintain mitochondrial metabolism; generation of antioxidants to remove reactive oxygen species; synthesis of nonessential amino acids (NEAAs), purines, pyrimidines, and fatty acids for cellular replication; and activation of cell signaling. In light of the pleiotropic role of glutamine in cancer cells, a comprehensive understanding of glutamine metabolism is essential for the development of metabolic therapeutic strategies for targeting cancer cells. In this article, we review oncogene-, tumor suppressor–, and tumor microenvironment–mediated regulation of glutamine metabolism in cancer cells. We describe the mechanism of glutamine's regulation of tumor proliferation, metastasis, and global methylation. Furthermore, we highlight the therapeutic potential of glutamine metabolism and emphasize that clinical application of in vivo assessment of glutamine metabolism is critical for identifying new ways to treat patients through glutamine-based metabolic therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-bioeng-071516-044546

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 3×
“In order to systematically understand the role of metabolic reprogramming in cancer cells on establishing and maintaining a tumorigenic status, Pavlova & Thompson (2) summarized”
Background
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“As tumors develop, cancer cells recruit nonmalignant stromal cells in their vicinity to form a highly interactive tumor microenvironment (137).”
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472

Show all 171 references

Research works printed but not linked: 8

Smolke CD, 2010, The Metabolic Pathway Engineering Handbook: Fundamentals
Matsuno T, 1992, Cancer Res, 52, 1192
10.1038/nature12040 · DOI · Paper page
10.1016/j.cell.2015.07.016 · DOI · Paper page
Pizer ES, 1996, Cancer Res, 56, 1189
Levine B, 2015, J. Clin. Investig., 12514
Majós C, 2004, Am. J. Neuroradiol., 25, 1696
10.1158/1535-7163.MCT-13-0870 · DOI · Paper page

Sorted by citations

Items 401–500 of 860

Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Chen, K.-C., Hsiao, I.-H., Huang, Y., Chou, Y.-T., Lin, Y., Hsieh, J., Chang, Y., Wu, K., Liu, G., & Hung, H. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00812-x · Cited by 15
The pan-cancer landscape of glutamate and glutamine metabolism: A comprehensive bioinformatic analysis across 32 solid cancer types.
Xue, W., Wu, K., Guo, X.-N., Chen, C.-X., Huang, T., Li, L.-F., Liu, B., Chang, H., & Zhao, J. (2023) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166982 · Cited by 18
Ambient PM2.5 orchestrates M1 polarization of alveolar macrophages via activating glutaminase 1-mediated glutaminolysis in acute lung injury
Su, J., Tu, Y., Hu, X., Wang, Y., Chen, M., Cao, X., Shao, M., Zhang, F., & Ding, W. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125467 · Cited by 17
Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
Li, D., Cao, D., Zhang, Y., Yu, X., Wu, Y., Jia, Z., Jiang, J., & Cao, X. (2025) · Scientific Reports · doi:10.1038/s41598-024-84916-w · Cited by 15
Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
Guo, Z., Ma, J., Zhang, J.-Q., Yan, L., Zhou, Y., Mao, X., Li, S.-W., & Zhou, X.-B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1524801 · Cited by 17
Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer
Thiruvalluvan, M., Billet, S., & Bhowmick, N. A. (2022) · Cancers · doi:10.3390/cancers14102491 · Cited by 15
Differential glutamine metabolism in the tumor microenvironment – studies in diversity and heterogeneity: A mini-review
Claiborne, M. D., & Leone, R. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1011191 · Cited by 16
A preclinical model of cutaneous melanoma based on reconstructed human epidermis
Leikeim, A., Wußmann, M., Schmidt, F. F., Neto, N. G. B., Benz, F., Tiltmann, K., Junger, C., Monaghan, M. G., Schilling, B., & Groeber-Becker, F. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-19307-0 · Cited by 17
Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer
Jiang, T., Yang, C. K., Ma, L., Wu, Z., Ye, L., Ma, X., Li, H., Fan, J., & Yang, Y. (2017) · Disease Markers · doi:10.1155/2017/1202710 · Cited by 15
Stress-induced extracellular vesicles: insight into their altered proteomic composition and probable physiological role in cancer
Bhavsar, V., Sahu, A., & Taware, R. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05121-x · Cited by 15
Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR ‐622/ SLC1A5 signaling axis
Wu, B., Chen, Y., Chen, Y., Xie, X., Liang, H., Peng, F., & Che, W. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14458 · Cited by 13
Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
Ngwa, V. M., Edwards, D. N., Hwang, Y., Karno, B. A., Wang, X., Yan, C. W., Richmond, A. J., Brantley‐Sieders, D. M., & Chen, J. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0048 · Cited by 13
HPV16 E6 and E7 Oncoproteins Stimulate the Glutamine Pathway Maintaining Cell Proliferation in a SNAT1-Dependent Fashion
Ortiz-Pedraza, Y., Muñoz-Bello, J. O., Ramos-Chávez, L. A., Martínez-Ramírez, I., Olmedo‐Nieva, L., Manzo-Merino, J., Saavedra, A. L., de la Cruz, V. P., & Lizano, M. (2023) · Viruses · doi:10.3390/v15020324 · Cited by 14
Metabolomics Approach Reveals Important Glioblastoma Plasma Biomarkers for Tumor Biology
Ferrasi, A. C., Puttini, R., Galvani, A. F., Filho, P. T. H., Delafiori, J., Argente, V. D., de Oliveira, A. N., Dias-Audibert, F. L., Catharino, R. R., Silva, O. C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108813 · Cited by 14
Largescale multicenter study of a serum metabolite biomarker panel for the diagnosis of breast cancer
Wang, Y., An, R., Yu, H., Dai, Y., Lou, L., Quan, S., Chen, R., Ding, Y., Zhao, H., Wu, X., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110345 · Cited by 14
BRAF and NRAS mutated melanoma: Different Ca2+ responses, Na+/Ca2+ exchanger expression, and sensitivity to inhibitors
Esteves, G. N. N., Ferraz, L. S., Alvarez, M. M. P., Costa, C. A., Lopes, R. D. M., Tersariol, I. L. S., & Rodrigues, T. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102241 · Cited by 14
Metabolic collaboration between cells in the tumor microenvironment has a negligible effect on tumor growth
Gustafsson, J., Roshanzamir, F., Hagnestål, A., Patel, S. M., Daudu, O. I., Becker, D., Robinson, J. L., & Nielsen, J. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100583 · Cited by 14
Metabolic Gatekeepers of Pathological B Cell Activation
Sadras, T., Chan, L. N., Xiao, G., & Müschen, M. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-061020-050135 · Cited by 17
Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma
Felkai, L., Krencz, I., Kiss, D. J., Nagy, N., Petővári, G., Dankó, T., Micsík, T., Khoor, A., Tornóczky, T., Sápi, Z., et al. (2020) · Cancers · doi:10.3390/cancers12071947 · Cited by 13
Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications
Chen, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05779-3 · Cited by 14
Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma
Wei, D., Chen, D., Mou, H., Chakraborty, S., Wei, B., Tan, L., Lorenzi, P. L., Qian, X., & Yang, P. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0490 · Cited by 13
Effect of differential deprivation of nutrients on cellular proliferation, oxidative stress, mitochondrial function, and cell migration in MDA-MB-231, HepG2, and HeLa cells
Prasad, A., Roy, A. C., Priya, K., Meena, R., & Ghosh, I. (2023) · 3 Biotech · doi:10.1007/s13205-023-03759-w · Cited by 14
Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma
Tambay, V., Raymond, V., Voisin, L., Meloche, S., & Bilodeau, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147558 · Cited by 13
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Shi, J., Han, W., Wang, J., & Kong, X. (2025) · Advanced Materials · doi:10.1002/adma.202415550 · Cited by 14
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancer
Andrieu, G. P., Simonin, M., Cabannes‐Hamy, A., Lengliné, É., Marçais, A., Théron, A., Huré, G., Doss, J., Nemazanyy, I., Dourthe, M.-É., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57225-7 · Cited by 13
1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1)
Primasová, H., Paul, L. E. H., Diserens, G., Primasová, E., Vermathen, P., Vermathen, M., & Furrer, J. (2019) · Metabolites · doi:10.3390/metabo9070146 · Cited by 13
A glance at the actual role of glutamine metabolism in thyroid tumorigenesis
Abooshahab, R., Hooshmand, K., Razavi, F., Dass, C. R., & Hedayati, M. (2021) · EXCLI journal · doi:10.17179/excli2021-3826 · Cited by 14
Hormone-Glutamine Metabolism: A Critical Regulatory Axis in Endocrine-Related Cancers
Xu, F., Shi, J., Qin, X., Zheng, Z., Chen, M., Lin, Z., Ye, J., & Li, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710086 · Cited by 15
The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism
Nagaoka, K., Mulla, J., Cao, K. Y., Cheng, Z., Liu, D., Mueller, W., Bay, A., Hildebrand, G., Lu, S., & Huang, C. (2020) · Liver Research · doi:10.1016/j.livres.2020.04.001 · Cited by 13
Carnosine suppresses human glioma cells under normoxic and hypoxic conditions partly via inhibiting glutamine metabolism
Fang, Y., Wu, M. T., Chen, H.-N., Wen, T., Lyu, J., & Shen, Y. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0488-1 · Cited by 13
Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach
Draguet, A., Tagliatti, V., & Colet, J. (2021) · Metabolites · doi:10.3390/metabo11080556 · Cited by 13
Depressive Disorder Affects TME and Hormonal Changes Promoting Tumour Deterioration Development
Dong, J., Du, J., Liu, R., Gao, X., Wang, Y., Ma, L., Yang, Y., Wu, J. H., Yu, J., & Liu, N. (2025) · Immunology · doi:10.1111/imm.13933 · Cited by 12
Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk
Ma, Z., Wang, S., Liu, S., Yang, W., Hu, J., Lv, L., Qian, Y., & Lu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1653442 · Cited by 16
Mitochondria-Mediated Mechanisms of Ferroptosis in Neurological Diseases
Zhong, R., Yang, H., Li, X., Wang, F., Zhai, L., & Gao, J. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04605-6 · Cited by 12
Preclinical studies for improving radiosensitivity of non-small cell lung cancer cell lines by combining glutaminase inhibition and senolysis
Fujimoto, M., Higashiyama, R., Yasui, H., Yamashita, K., & Inanami, O. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101431 · Cited by 12
The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis
Stuart, S. F., Bezawork‐Geleta, A., Areeb, Z., Gomez, J., Tsui, V., Zulkifli, A., Paradiso, L., Jones, J., Nguyen, H. P. T., Putoczki, T. L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043356 · Cited by 12
The regulation of amino acid metabolism in tumor cell death: from the perspective of physiological functions
Wang, J., Wang, H., Gao, M., Zhang, Y., Zhang, L., Huang, D., Tu, K., & Xu, Q. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01875-9 · Cited by 14
Impact of Chromium Picolinate on Leydig Cell Steroidogenesis and Antioxidant Balance Using an In Vitro Insulin Resistance Model
Moreira, R., Martins, A. D., Ferreira, R. M., Alves, M. G., Pereira, M. D. L., & Oliveira, P. F. (2023) · Antioxidants · doi:10.3390/antiox13010040 · Cited by 14
Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1
Zhu, G., Guan, F., Li, S., Zhang, Q. H., Zhang, X., Qin, Y., Sun, Z., Peng, S., Cheng, J., Li, Y., et al. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23696 · Cited by 12
Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugs
Novotná, K., Tenora, L., Slusher, B. S., & Rais, R. (2024) · Advances in pharmacology · doi:10.1016/bs.apha.2024.04.003 · Cited by 12
Evidence for metabolism of creatine by the conceptus, placenta, and uterus for production of adenosine triphosphate during conceptus development in pigs
Lefevre, C. M., Cain, J. W., Kramer, A. C., Seo, H., Lopez, A. N., Sah, N., Wu, G., Bazer, F. W., & Johnson, G. A. (2024) · Biology of Reproduction · doi:10.1093/biolre/ioae088 · Cited by 12
Microbiota independent effects of oligosaccharides on Caco-2 cells -A semi-targeted metabolomics approach using DI-FT-ICR-MS coupled with pathway enrichment analysis
Jensen‐Kroll, J., Demetrowitsch, T. J., Clawin‐Rädecker, I., Klempt, M., Waschina, S., & Schwarz, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.968643 · Cited by 12
Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer
Choi, S. Y. C., Ribeiro, C. F., Wang, Y. Z., Loda, M. F., Plymate, S. R., & Uo, T. (2022) · Biomolecules · doi:10.3390/biom12111590 · Cited by 13
Warburg Effect Revisited: Embodiment of Classical Biochemistry and Organic Chemistry. Current State and Prospects
Menchikov, L. G., Shestov, A. A., & Popov, A. V. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923140018 · Cited by 12
Glutamine catabolism supports amino acid biosynthesis and suppresses the integrated stress response to promote photoreceptor survival
Goswami, M. T., Weh, E., Subramanya, S., Weh, K. M., Durumutla, H. B., Hager, H. M., Miller, N., Chaudhury, S., Andren, A. C., Sajjakulnukit, P., et al. (2025) · eLife · doi:10.7554/elife.100747.3 · Cited by 11
Mechano‐Iontronic Hydrogels Generating Biomimetic Endogenous Bioelectricity for Promoting Cartilage Regeneration
Li, L., Li, Z., Yue, M., Shao, Y., Wang, J., Song, Y., Wang, Z. L., Zhou, Y., & Pu, X. (2025) · Advanced Materials · doi:10.1002/adma.202514604 · Cited by 13
Enhancement of de novo lipogenesis by the IDH1 and IDH2-dependent reverse TCA cycle maintains the growth and angiogenic capacity of bone marrow-derived endothelial progenitor cells under hypoxia
He, Q., Yu, T., Chen, J., Liang, J., Lin, D., Yan, K., Zi-jing, X., Song, Y., & Chen, Z. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.028 · Cited by 11
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy
Masci, D., Puxeddu, M., Silvestri, R., & Regina, G. L. (2024) · Molecules · doi:10.3390/molecules29092110 · Cited by 11
Unravelling the molecular landscape of endometrial cancer subtypes: insights from multiomics analysis
Shen, Y., Tian, Y., Ding, J., Chen, Z., Rong, Z., Lu, Y., Li, L., Zhang, H., Wu, H., Li, X., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001685 · Cited by 11
Glutaminolysis is a Potential Therapeutic Target for Kidney Diseases
Ou, L., Liu, Y., Qiu, S.-T., Yang, C., Tang, J., Li, X., Liu, H., & Ye, Z.-N. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s471711 · Cited by 11
Aerobic glycolysis but not GLS1-dependent glutamine metabolism is critical for anti-tumor immunity and response to checkpoint inhibition
Gubser, P. M., Wijesinghe, S. K. M., Heyden, L., Gabriel, S. S., Souza, D. P. D., Hess, C., McConville, M. M., Utzschneider, D. T., & Kallies, A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114632 · Cited by 14
Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy
Zhang, J., Su, Y., Wang, X., Yao, X., & Du, J. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.2001 · Cited by 13
Fighting ischemia-reperfusion injury: Focusing on mitochondria-derived ferroptosis
Tian, L., Liu, Q., Guo, H. W., Zang, H., & Li, Y. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101974 · Cited by 15
The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis
Pu, X., Wu, Y., Long, W., Sun, X., Yuan, X., Wang, D., Wang, X., & Xu, M. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03736-8 · Cited by 11
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents
Vagaggini, C., D’Ursi, P., Poggialini, F., Fossa, P., Francesconi, V., Trombetti, G., Orro, A., Dreassi, E., Schenone, S., Tonelli, M., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108523 · Cited by 12
Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and A Multi-omics anticancer approach
Mir, R., Javid, J., Ullah, M. F., Alrdahe, S. S., Albalawi, I. A., Mustafa, S. K., Jalal, M. M., Altayar, M. A., Albalawi, A. D., Abunab, M. K., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02945-5 · Cited by 12
Nrf2 drives activation-driven expansion of CD4+T cells by modulating glucose and glutamine metabolism
Tripathi, A., Dasgupta, D., Dahabieh, M. S., Griffard-Smith, R., Pant, A., Bugbee, A., Yellapu, N. K., Burt, E., Choi, B. H. Y., Ellis, A. E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116177 · Cited by 12
Hyperosmolarity Triggers the Warburg Effect in Chinese Hamster Ovary Cells and Reveals a Reduced Mitochondria Horsepower
Moreira, J. D. V., Staercke, L. D., Martínez-Basilio, P. C., Gauthier-Thibodeau, S., Montégut, L., Schwartz, L. H., & Jolicœur, M. (2021) · Metabolites · doi:10.3390/metabo11060344 · Cited by 11
MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells
Yi, C., & Yu, A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.893846 · Cited by 12
Amino acids in hematologic malignancies: Current status and future perspective
Wang, M., Zhao, A., Li, M., & Niu, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1113228 · Cited by 11
Is the Response of Tumours Dependent on the Dietary Input of Some Amino Acids or Ratios among Essential and Non-Essential Amino Acids? All That Glitters Is Not Gold
Dioguardi, F. S., Flati, V., Corsetti, G., Pasini, E., & Romano, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113631 · Cited by 11
Targeting SLC1A5 blocks cell proliferation through inhibition of mTORC1 in arsenite-treated human uroepithelial cells
Li, S., Zhou, Q., Liu, W., Fu, Z., Zhao, H., & Xi, S. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.03.007 · Cited by 11
Metabolic reprogramming and cancer precision medicine: a narrative review
Zhang, H., & Tang, S. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-21-27 · Cited by 11
Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers
Dabbour, N. M., Salama, A. M., Donia, T., Al-Deeb, R. T., Elghane, A. M. A., Badry, K. H., & Loutfy, S. A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103022 · Cited by 11
Extreme, but not moderate climate scenarios, impart sublethal effects on polyps of the Irukandji jellyfish, Carukia barnesi
Boco, S. R., Pitt, K. A., & Melvin, S. D. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.451 · Cited by 12
Metabolite-dependent m6A methylation driven by mechanotransduction-metabolism-epitranscriptomics axis promotes bone development and regeneration
Li, Z., Guo, Z., Yang, Z., Yang, B., Hu, Y., Xie, X., Zong, Z., Chen, Z., Zhang, K., Zhao, P., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115611 · Cited by 10
Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism
Tu, H., Yin, X., Wen, J., Wu, W., Zhai, B., Li, J., & Jiang, H. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.007 · Cited by 10
Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells
Premaratne, A., Ho, C., Basu, S., Khan, A. F., Bawa‐Khalfe, T., & Lin, C. (2023) · Biomolecules · doi:10.3390/biom13020345 · Cited by 10
Intracellular spatiotemporal metabolism in connection to target engagement
Zhang, J., Qiu, Z., Zhang, Y. J., Wang, G., & Hao, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115024 · Cited by 10
Macrophage immunometabolism in diabetes-associated atherosclerosis
dos Santos, B. G., & Goedeke, L. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000032 · Cited by 11
Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy
Blanchard, R., & Adjei, I. M. (2023) · RSC Advances · doi:10.1039/d3ra01153d · Cited by 11
Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging
Zhang, H., Muhetarijiang, M., Chen, R. J., Hu, X., Han, J., Zheng, L., & Chen, T. (2024) · Aging and Disease · doi:10.14336/ad.2024.0058 · Cited by 12
The Role and Treatment Strategies of Ammonia-Related Metabolism in Tumor Microenvironment
Ye, Q., Li, D., Zou, Y., & Yuan, Y. (2024) · Current Gene Therapy · doi:10.2174/0115665232301222240603100840 · Cited by 10
Metabolomics for hematologic malignancies: Advances and perspective
Li, X., Xu, M., Chen, Y., Zhai, Y., Li, J., Zhang, N., Yin, J., & Wang, L. (2024) · Medicine · doi:10.1097/md.0000000000039782 · Cited by 10
GlutaR: A High‐Performance Fluorescent Protein‐Based Sensor for Spatiotemporal Monitoring of Glutamine Dynamics In Vivo
Liu, B., Zhao, Z., Wang, P., Aihemaiti, K., Zhu, L., Wei, Q., Li, W., Yuan, X., Wu, J., Jiang, C., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202416608 · Cited by 10
Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis
Huang, Y., Lu, H., Liu, Y. Z., Wang, J., Xia, Q., Shi, X., Jin, Y., Liang, X., Wang, W., Ma, X., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-024-00359-z · Cited by 10
The LncRNA FEZF1-AS1 promotes tumor proliferation in colon cancer by regulating the mitochondrial protein PCK2
WANG, H., Wu, Y., WANG, Z., CHEN, Y., MO, J., GUAN, W., ZHANG, Y., & Yao, H. (2021) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.03553 · Cited by 10
CRISPR Cas9-mediated ablation of pyruvate carboxylase gene in colon cancer cell line HT-29 inhibits growth and migration, induces apoptosis and increases sensitivity to 5-fluorouracil and glutaminase inhibitor
Ngamkham, J., Siritutsoontorn, S., Saisomboon, S., Vaeteewoottacharn, K., & Jitrapakdee, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.966089 · Cited by 12
The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease
Lungu, O., Toscani, D., Burroughs-Garcia, J., & Giuliani, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054893 · Cited by 10
Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
Hellmann, A. R., Turyn, J., Zwara, A., Korczyńska, J., Taciak, A., & Mika, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1199291 · Cited by 10
Glycine metabolomic changes induced by anticancer agents in A549 cells
Guo, K., Cao, Y., Li, Z., Zhou, X., Ding, R., Chen, K., Liu, Y., Qiu, Y., Wu, Z., & Fang, M. (2020) · Amino Acids · doi:10.1007/s00726-020-02853-0 · Cited by 13
Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer
Wang, H., Ma, Z., Cheng, X., Tuo, B., Liu, X., & Li, T. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s280797 · Cited by 10
hsa_circ_0000518 Facilitates Non-Small-Cell Lung Cancer Progression via Moderating miR-330-3p and Positively Regulating SLC1A5
Lv, H., Shi, Z., Sui, A., Zhang, Y., Peng, L., Wang, M., & Zhang, F. (2022) · Journal of Immunology Research · doi:10.1155/2022/4996980 · Cited by 10
A Proposed Association between Improving Energy Metabolism of HepG2 Cells by Plant Extracts and Increasing Their Sensitivity to Doxorubicin
Al‐Shafie, T. A., Mahrous, E. A., Shukry, M., Alshahrani, M. Y., Ibrahim, S. F., Fericean, L. M., Abdelkader, A., & Ali, M. A. (2023) · Toxics · doi:10.3390/toxics11020182 · Cited by 11
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Tang, Y.-C., Chuang, Y., Chang, H.-H., Juang, S., Yen, G., Chang, J.-Y., & Kuo, C. (2023) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3463 · Cited by 11
A comparative analysis of fruit fly and human glutamate dehydrogenases in Drosophila melanogaster sperm development
Vedelek, V., Vedelek, B., Lőrincz, P., Juhász, G., & Sinka, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1281487 · Cited by 9
Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer
He, X., Guan, X., & Li, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1532605 · Cited by 14
13C-metabolic flux analysis of Saccharomyces cerevisiae in complex media
Fujiwara, H., Okahashi, N., Seike, T., & Matsuda, F. (2025) · Metabolic Engineering Communications · doi:10.1016/j.mec.2025.e00260 · Cited by 9
The Landscape of Cancer Metabolism as a Therapeutic Target
Ohshima, K. (2025) · Pathology International · doi:10.1111/pin.70034 · Cited by 11
Regulation of dendritic cell biology by amino acids and their transporters
Chen, S.-L., Li, G., Jiang, Z., Xu, Y., Aipire, A., & Li, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1626973 · Cited by 13
Circular RNAs as central regulators of metabolic reprogramming and immune responses in the breast cancer microenvironment: A comprehensive review
Sherafat, N. S., Mardi, A., Absalan, F., & Mehmandar‐Oskuie, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118682 · Cited by 11
Metabolic reprogramming-driven resistance to multi-kinase inhibitors in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities
Li, J., Huang, Y., Li, J., Shi, M., Xiao, Y., Du, F., & Hu, G. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02578-w · Cited by 10
ZFTA–RELA ependymomas make itaconate to epigenetically drive fusion expression
Natarajan, S. K., Lum, J., Skeans, J. H., Nenwani, M., Eyunni, S., Mota, M., Bayliss, J. M., Deogharkar, A., Hamanishi, E. T., Pun, M. J., et al. (2026) · Nature · doi:10.1038/s41586-025-10005-1 · Cited by 11
Self-citation
MicroRNAs and Metabolism: Revisiting the Warburg Effect with Emphasis on Epigenetic Background and Clinical Applications
Gaál, Z. (2021) · Biomolecules · doi:10.3390/biom11101531 · Cited by 9
Metabolic changes in glioblastomas in response to choline kinase inhibition: In vivo MRS in rodent models
Bhaduri, S., Kelly, C. L., Lesbats, C., Sharkey, J. W., Ressel, L., Mukherjee, S., Platt, M., Delikatny, E. J., & Poptani, H. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4855 · Cited by 8
Potential Therapeutic Targets in Ovarian Cancer: Autophagy and Metabolism
Park, M., Choe, S., Shin, M., Kim, A., Mo, K., Kwon, H., & Yoon, H. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803047 · Cited by 9
Metabolic Regulation of the NLRP3 Inflammasome
Ye, Q., Chen, S., & Wang, D. (2021) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000057 · Cited by 9
Nanoconfined liquid phase nanoextraction combined with in-fiber derivatization for simultaneous quantification of seventy amino-containing metabolites in plasma by LC-MS/MS: Exploration of lung cancer screening model
Yu, C., Zhang, Q., Wang, L., Zhang, Y., Cui, M., Kai-shun, B., Li, D., & Li, Q. (2022) · Talanta · doi:10.1016/j.talanta.2022.123452 · Cited by 9
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
van Genugten, E. A. J., Weijers, J. A. M., Heskamp, S., Kneilling, M., van den Heuvel, M. M., Piet, B., Bussink, J., Hendriks, L. E. L., & Aarntzen, E. H. J. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786089 · Cited by 9
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion
Bishop, E., Dimitrova, M., Froggatt, A., Estevez-Cebrero, M. D. L. A., Storer, L. C. D., Mussai, F., Paine, S., Grundy, R. G., & Dandapani, M. (2022) · BioMed Research International · doi:10.1155/2022/9008685 · Cited by 8

Authors: Yang, L., Venneti, S., & Nagrath, D.
Affiliations: Rice University (US)
University of Michigan (US)
ORCID: Yang, Lifeng
Venneti, Sriram
Nagrath, Deepak
Venue: Annual Review of Biomedical Engineering
Publisher: Annual Reviews
Published: 2017-06-21
Volume: 19
Issue: 1
Pages: 163-194
ISSN: 1523-9829 (ISSN-L)
1545-4274
DOI: 10.1146/annurev-bioeng-071516-044546
OpenAlex: W2534904302
Cited by: 859
References: 171
Citations by year: 2026: 68 · 2025: 140 · 2024: 137 · 2023: 132 · 2022: 126 · 2021: 98 · 2020: 71 · 2019: 46 · 2018: 28 · 2017: 13
FWCI: 4.43
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Annual Review of Biomedical Engineering (publishedVersion)
PubMed (publishedVersion)
Rice Research Repository (Rice University) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Keywords: glutamine metabolism, glutaminolysis, cancer metabolism, tumor microenvironment, oncogenes, tumor suppressor, metastasis, global DNA methylation, tumor cell proliferation, metabolic therapy, reactive oxygen species, purine and pyrimidine synthesis, signal transduction
MeSH terms: Animals, Cell Transformation, Neoplastic, Glutamine, Humans, Mitochondria, Models, Biological, Neoplasms, Biomarkers, Tumor, Signal Transduction, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glutaminolysis: A Hallmark of Cancer Metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks